Dr. Lal is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 1st St SW
Rochester, MN 55905Phone+1 507-284-2511
Summary
- Dr. Amos Lal is an intensivist in Rochester, MN. He received his medical degree from Christian Medical College Vellore and has been in practice 6 years. He specializes in critical care medicine and is experienced in critical care medicine, health technology/informatics, and clinical research focused on improving outcomes in critically ill.
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Pulmonary Disease, 2021 - 2023
Mayo Clinic College of Medicine and Science (Rochester)MS, Biomedical Sciences, Clinical and Translational Science, 2020 - 2023- Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Pulmonary Disease and Critical Care Medicine, 2019 - 2021
St Vincent HospitalResidency, Internal Medicine, 2016 - 2019- Ministry of Health Holdings, SingaporeEmergency and Critical Care Medicine, 2013 - 2016
- Frances Newton Mission HospitalMedical and Surgical Critical Care, 2011 - 2013
Christian Medical College VelloreClass of 2011
Certifications & Licensure
FL State Medical License 2023 - Present
MN State Medical License 2019 - 2025
WI State Medical License 2023 - 2025
MA State Medical License 2016 - 2019- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 10 citationsA review of the presentation and outcome of left ventricular thrombus in coronavirus disease 2019 infection.Anil Mathew Philip, Lina James George, Kevin John John, Anu Anna George, Jemimah Nayar
Journal of Clinical and Translational Research. 2021-12-28 - 42 citationsA review of cardiac manifestations and predictors of outcome in patients with COVID - 19.Ajay Kumar Mishra, Kamal Kant Sahu, Anu Anna George, Amos Lal
Heart & Lung. 2020-05-03 - 15 citationsInfection risk with the use of interleukin inhibitors in hospitalized patients with COVID-19: A narrative review.Thoyaja Koritala, Vishwanath Pattan, Raghavendra Tirupathi, Ali A Rabaan, Abbas Al Mutair
Le Infezioni in Medicina. 2021-01-01
Authored Content
- Serious Cover-up: Hodgkin's Lymphoma Masked by Organizing PneumoniaApril 2018
Press Mentions
Digital Twin Model Predicts Sepsis MortalityOctober 30th, 2024
Physiologic Approach to Diuresis in De-Resuscitation Phase in Intensive CareMay 28th, 2020- Closed-Loop Insulin for Glycemic Control in Noncritical CareNovember 15th, 2018
- Join now to see all
Professional Memberships
- Fellow
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
